Actionable news
All posts from Actionable news
Actionable news in PFE: PFIZER Inc,

Pfizer revenue misses as demand falls for older drugs, Prevnar

(Reuters) - Pfizer Inc's (PFE.N) quarterly revenue missed Wall Street estimates on Tuesday, hurt by falling demand for its blockbuster pneumonia vaccine Prevnar as well as older drugs.

Sales of Prevnar declined 8.2 percent to $1.15 billion, largely due to the timing of government purchases for the pediatric indication.

Sales of its copycat generics and biosimilars fell 13.5 percent in the quarter to $5.23 billion.

"Pfizer's ambition of stabilizing this book of business looks some way off," Berenburg analysts said in a note.

Revenue from its patent-protected drugs rose about 8 percent to $7.67 billion in the quarter.

Sales of its key drugs, including rheumatoid arthritis...